On average, analysts expect that Silverback Therapeutics will post -2.04 EPS for the current fiscal year. The company reported ($0.70) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.67) by ($0.03). Silverback Therapeutics ( NASDAQ:SBTX – Get Rating) last announced its earnings results on Thursday, May 12th. Silverback Therapeutics has a 52-week low of $2.80 and a 52-week high of $35.63. The stock has a fifty day simple moving average of $3.36 and a 200-day simple moving average of $4.36. 85.98% of the stock is owned by hedge funds and other institutional investors. Finally, Ensign Peak Advisors Inc acquired a new stake in shares of Silverback Therapeutics during the 4th quarter valued at $2,730,000. Morgan Stanley now owns 638,701 shares of the company’s stock valued at $6,374,000 after purchasing an additional 625,477 shares in the last quarter. Morgan Stanley boosted its holdings in shares of Silverback Therapeutics by 4,729.9% in the 3rd quarter. Millennium Management LLC now owns 953,691 shares of the company’s stock worth $9,518,000 after purchasing an additional 944,661 shares during the period.
Millennium Management LLC increased its stake in shares of Silverback Therapeutics by 10,461.4% during the third quarter. now owns 2,974,228 shares of the company’s stock valued at $10,440,000 after buying an additional 1,200,538 shares during the last quarter. lifted its position in shares of Silverback Therapeutics by 67.7% in the first quarter. Nextech Invest AG bought a new position in Silverback Therapeutics in the 4th quarter worth approximately $12,721,000. Based on an average daily volume of 407,000 shares, the short-interest ratio is presently 2.6 days.Ī number of institutional investors have recently made changes to their positions in SBTX. Approximately 5.2% of the shares of the company are sold short. As of May 31st, there was short interest totalling 1,060,000 shares, a decrease of 16.5% from the May 15th total of 1,270,000 shares. ( NASDAQ:SBTX – Get Rating) saw a significant decrease in short interest in the month of May.
0 kommentar(er)
